Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Influenza

  Free Subscription


Articles published in J Exp Med

Retrieve available abstracts of 51 articles:
HTML format



Single Articles


    July 2021
  1. BASTARD P, Orlova E, Sozaeva L, Levy R, et al
    Preexisting autoantibodies to type I IFNs underlie critical COVID-19 pneumonia in patients with APS-1.
    J Exp Med. 2021;218.
    PubMed     Abstract available


  2. SOLFOROSI L, Kuipers H, Jongeneelen M, Rosendahl Huber SK, et al
    Immunogenicity and efficacy of one and two doses of Ad26.COV2.S COVID vaccine in adult and aged NHP.
    J Exp Med. 2021;218.
    PubMed     Abstract available


    June 2021
  3. LANZ C, Schotsaert M, Magnus C, Karakus U, et al
    IFITM3 incorporation sensitizes influenza A virus to antibody-mediated neutralization.
    J Exp Med. 2021;218.
    PubMed     Abstract available


  4. SANCHO-SHIMIZU V, Brodin P, Cobat A, Biggs CM, et al
    SARS-CoV-2-related MIS-C: A key to the viral and genetic causes of Kawasaki disease?
    J Exp Med. 2021;218.
    PubMed     Abstract available


    May 2021
  5. ANDREANO E, Rappuoli R
    Immunodominant antibody germlines in COVID-19.
    J Exp Med. 2021;218.
    PubMed     Abstract available


  6. LE BERT N, Clapham HE, Tan AT, Chia WN, et al
    Highly functional virus-specific cellular immune response in asymptomatic SARS-CoV-2 infection.
    J Exp Med. 2021;218.
    PubMed     Abstract available


  7. MERAD M, Vabret N
    Highlights from a year in a pandemic.
    J Exp Med. 2021;218.
    PubMed     Abstract available


  8. BAUM A, Kyratsous CA
    SARS-CoV-2 spike therapeutic antibodies in the age of variants.
    J Exp Med. 2021;218.
    PubMed     Abstract available


  9. KEDL RM
    Down but far from out: The durability of SARS-CoV-2 immunity after asymptomatic infection.
    J Exp Med. 2021;218.
    PubMed     Abstract available


    April 2021
  10. ZHUANG Z, Lai X, Sun J, Chen Z, et al
    Mapping and role of T cell response in SARS-CoV-2-infected mice.
    J Exp Med. 2021;218.
    PubMed     Abstract available


  11. ONODI F, Bonnet-Madin L, Meertens L, Karpf L, et al
    SARS-CoV-2 induces human plasmacytoid predendritic cell diversification via UNC93B and IRAK4.
    J Exp Med. 2021;218.
    PubMed     Abstract available


  12. BRETON G, Mendoza P, Hagglof T, Oliveira TY, et al
    Persistent cellular immunity to SARS-CoV-2 infection.
    J Exp Med. 2021;218.
    PubMed     Abstract available


  13. BASTARD P, Michailidis E, Hoffmann HH, Chbihi M, et al
    Auto-antibodies to type I IFNs can underlie adverse reactions to yellow fever live attenuated vaccine.
    J Exp Med. 2021;218.
    PubMed     Abstract available


  14. POON MML, Farber DL
    Lasting memories of SARS-CoV-2 infection.
    J Exp Med. 2021;218.
    PubMed     Abstract available


    March 2021
  15. SCHAFER A, Muecksch F, Lorenzi JCC, Leist SR, et al
    Antibody potency, effector function, and combinations in protection and therapy for SARS-CoV-2 infection in vivo.
    J Exp Med. 2021;218.
    PubMed     Abstract available


  16. LU Y, Jiang R, Freyn AW, Wang J, et al
    CD4+ follicular regulatory T cells optimize the influenza virus-specific B cell response.
    J Exp Med. 2021;218.
    PubMed     Abstract available


  17. RODRIGUES TS, de Sa KSG, Ishimoto AY, Becerra A, et al
    Inflammasomes are activated in response to SARS-CoV-2 infection and are associated with COVID-19 severity in patients.
    J Exp Med. 2021;218.
    PubMed     Abstract available


  18. BRYANT C
    COVID-19 stokes inflammasomes.
    J Exp Med. 2021;218.
    PubMed     Abstract available


  19. SONG E, Zhang C, Israelow B, Lu-Culligan A, et al
    Neuroinvasion of SARS-CoV-2 in human and mouse brain.
    J Exp Med. 2021;218.
    PubMed     Abstract available


    January 2021
  20. PAIK DH, Farber DL
    Influenza infection fortifies local lymph nodes to promote lung-resident heterosubtypic immunity.
    J Exp Med. 2021;218.
    PubMed     Abstract available


    December 2020
  21. ISRAELOW B, Song E, Mao T, Lu P, et al
    Mouse model of SARS-CoV-2 reveals inflammatory role of type I interferon signaling.
    J Exp Med. 2020;217.
    PubMed     Abstract available


  22. JOUAN Y, Guillon A, Gonzalez L, Perez Y, et al
    Phenotypical and functional alteration of unconventional T cells in severe COVID-19 patients.
    J Exp Med. 2020;217.
    PubMed     Abstract available


  23. VERAS FP, Pontelli MC, Silva CM, Toller-Kawahisa JE, et al
    SARS-CoV-2-triggered neutrophil extracellular traps mediate COVID-19 pathology.
    J Exp Med. 2020;217.
    PubMed     Abstract available


  24. RADERMECKER C, Detrembleur N, Guiot J, Cavalier E, et al
    Neutrophil extracellular traps infiltrate the lung airway, interstitial, and vascular compartments in severe COVID-19.
    J Exp Med. 2020;217.
    PubMed     Abstract available


  25. MAJOR J, Wack A
    An ace model for SARS-CoV-2 infection.
    J Exp Med. 2020;217.
    PubMed     Abstract available


  26. KOAY HF, Fulford TS, Godfrey DI
    An unconventional view of COVID-19 T cell immunity.
    J Exp Med. 2020;217.
    PubMed     Abstract available


    November 2020
  27. SCHMIDT F, Weisblum Y, Muecksch F, Hoffmann HH, et al
    Measuring SARS-CoV-2 neutralizing antibody activity using pseudotyped and chimeric viruses.
    J Exp Med. 2020;217.
    PubMed     Abstract available


  28. SHUBINA M, Tummers B, Boyd DF, Zhang T, et al
    Necroptosis restricts influenza A virus as a stand-alone cell death mechanism.
    J Exp Med. 2020;217.
    PubMed     Abstract available


  29. KIM JH
    SARS-CoV-2 vaccine development, access, and equity.
    J Exp Med. 2020;217.
    PubMed     Abstract available


    October 2020
  30. CASSOTTA A, Paparoditis P, Geiger R, Mettu RR, et al
    Deciphering and predicting CD4+ T cell immunodominance of influenza virus hemagglutinin.
    J Exp Med. 2020;217.
    PubMed     Abstract available


  31. ZHOU T, Su TT, Mudianto T, Wang J, et al
    Immune asynchrony in COVID-19 pathogenesis and potential immunotherapies.
    J Exp Med. 2020;217.
    PubMed     Abstract available


    September 2020
  32. KOENIG LM, Boehmer DFR, Metzger P, Schnurr M, et al
    Blocking inflammation on the way: Rationale for CXCR2 antagonists for the treatment of COVID-19.
    J Exp Med. 2020;217.
    PubMed     Abstract available


  33. NATHAN C
    Neutrophils and COVID-19: Nots, NETs, and knots.
    J Exp Med. 2020;217.
    PubMed     Abstract available


  34. FREEDMAN TS, Headley MB, Serwas N, Ruhland M, et al
    Lessons of COVID-19: A roadmap for post-pandemic science.
    J Exp Med. 2020;217.
    PubMed     Abstract available


  35. HOUSTON S
    Lessons of COVID-19: Virtual conferences.
    J Exp Med. 2020;217.
    PubMed     Abstract available


    August 2020
  36. STOLLEY JM, Johnston TS, Soerens AG, Beura LK, et al
    Retrograde migration supplies resident memory T cells to lung-draining LN after influenza infection.
    J Exp Med. 2020;217.
    PubMed     Abstract available


  37. DIAMOND B
    The renin-angiotensin system: An integrated view of lung disease and coagulopathy in COVID-19 and therapeutic implications.
    J Exp Med. 2020;217.
    PubMed     Abstract available


    June 2020
  38. BARNES BJ, Adrover JM, Baxter-Stoltzfus A, Borczuk A, et al
    Targeting potential drivers of COVID-19: Neutrophil extracellular traps.
    J Exp Med. 2020;217.
    PubMed     Abstract available


  39. VARDHANA SA, Wolchok JD
    The many faces of the anti-COVID immune response.
    J Exp Med. 2020;217.
    PubMed     Abstract available


    May 2020
  40. NATHAN CF, Nussenzweig MC, Pulvirenti T
    We are here for you and ready to hear from you.
    J Exp Med. 2020;217.
    PubMed    


  41. WEISS SR
    Forty years with coronaviruses.
    J Exp Med. 2020;217.
    PubMed     Abstract available


  42. PROKUNINA-OLSSON L, Alphonse N, Dickenson RE, Durbin JE, et al
    COVID-19 and emerging viral infections: The case for interferon lambda.
    J Exp Med. 2020;217.
    PubMed     Abstract available


    June 2019
  43. LIM HK, Huang SXL, Chen J, Kerner G, et al
    Severe influenza pneumonitis in children with inherited TLR3 deficiency.
    J Exp Med. 2019 Jun 19. pii: jem.20181621. doi: 10.1084/jem.20181621.
    PubMed     Abstract available


    January 2019
  44. KOSIK I, Angeletti D, Gibbs JS, Angel M, et al
    Neuraminidase inhibition contributes to influenza A virus neutralization by anti-hemagglutinin stem antibodies.
    J Exp Med. 2019 Jan 25. pii: jem.20181624. doi: 10.1084/jem.20181624.
    PubMed     Abstract available


    August 2018
  45. HERNANDEZ N, Melki I, Jing H, Habib T, et al
    Life-threatening influenza pneumonitis in a child with inherited IRF9 deficiency.
    J Exp Med. 2018 Aug 24. pii: jem.20180628. doi: 10.1084/jem.20180628.
    PubMed     Abstract available


    February 2018
  46. LYNCH JP, Werder RB, Loh Z, Sikder MAA, et al
    Plasmacytoid dendritic cells protect from viral bronchiolitis and asthma through semaphorin 4a-mediated T reg expansion.
    J Exp Med. 2018;215:537-557.
    PubMed     Abstract available


    July 2017
  47. LAMBORN IT, Jing H, Zhang Y, Drutman SB, et al
    Recurrent rhinovirus infections in a child with inherited MDA5 deficiency.
    J Exp Med. 2017;214:1949-1972.
    PubMed     Abstract available


    June 2017
  48. KESAVARDHANA S, Kuriakose T, Guy CS, Samir P, et al
    ZBP1/DAI ubiquitination and sensing of influenza vRNPs activate programmed cell death.
    J Exp Med. 2017 Jun 20. pii: jem.20170550. doi: 10.1084/jem.20170550.
    PubMed     Abstract available


    April 2017
  49. DEEG CM, Hassan E, Mutz P, Rheinemann L, et al
    In vivo evasion of MxA by avian influenza viruses requires human signature in the viral nucleoprotein.
    J Exp Med. 2017 Apr 10. pii: jem.20161033. doi: 10.1084/jem.20161033.
    PubMed     Abstract available


    February 2017
  50. FU B, Wang L, Li S, Dorf ME, et al
    ZMPSTE24 defends against influenza and other pathogenic viruses.
    J Exp Med. 2017 Feb 28. pii: jem.20161270. doi: 10.1084/jem.20161270.
    PubMed     Abstract available


    January 2017
  51. GLENN JD, Smith MD, Xue P, Chan-Li Y, et al
    CNS-targeted autoimmunity leads to increased influenza mortality in mice.
    J Exp Med. 2017 Jan 5. pii: jem.20160517. doi: 10.1084/jem.20160517.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Influenza is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: